Detalhe da pesquisa
1.
Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals.
PLoS Pathog
; 19(11): e1011744, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37910480
2.
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study.
Mov Disord
; 37(7): 1516-1525, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607776
3.
Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial.
Front Neurol
; 15: 1303402, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38638315
4.
Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2-11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study.
Lancet Reg Health Am
; 34: 100750, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699214
5.
Phycocyanobilin promotes PC12 cell survival and modulates immune and inflammatory genes and oxidative stress markers in acute cerebral hypoperfusion in rats.
Toxicol Appl Pharmacol
; 272(1): 49-60, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23732081
6.
Efficacy and Safety of a Protein-Based SARS-CoV-2 Vaccine: A Randomized Clinical Trial.
JAMA Netw Open
; 6(5): e2310302, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133864
7.
Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial.
Lancet Reg Health Am
; 18: 100423, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36618081
8.
Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.
Int J Infect Dis
; 126: 164-173, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403819
9.
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.
Vaccine
; 40(13): 2068-2075, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35164986
10.
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial.
Lancet Respir Med
; 10(8): 785-795, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691295
11.
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults.
Med
; 3(11): 760-773.e5, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998623
12.
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine
; 40(31): 4220-4230, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691871
13.
Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: results from a cohort study.
Inflamm Res
; 60(3): 289-97, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20976525
14.
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial.
Lancet Reg Health Am
; 4: 100079, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541571
15.
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study.
BMC Pharmacol
; 10: 15, 2010 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21092287
16.
Immunoglobulin E-dependent regulation of the CCR3 chemokine receptor by interferon-gamma in atopic asthmatics.
Int Arch Allergy Immunol
; 148(3): 219-27, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18849613
17.
Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.
Int Wound J
; 6(6): 432-43, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20051095
18.
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.
BMC Infect Dis
; 8: 17, 2008 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-18267006
19.
Beneficial effects of oral administration of C-Phycocyanin and Phycocyanobilin in rodent models of experimental autoimmune encephalomyelitis.
Life Sci
; 194: 130-138, 2018 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29287781
20.
Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
Int Wound J
; 4(4): 333-43, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17953679